Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
RadTox™ Test
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
DiaCarta
Type:
CE Marked
Related tests:
‹
ColoScape™ Colorectal Cancer Mutation Detection Test
OptiSeq™ BRCA1 and BRCA2 Panel
OptiSeq™ Colorectal Cancer Panel
OptiSeq™ Lung Cancer & Colon Cancer Early Detection Panel
OptiSeq™ Lung Cancer Panel
OptiSeq™ Pan-Cancer Gene Panel
QClamp® BRAF Mutation Detection Test
QClamp® EGFR Mutation Detection Test
QClamp® JAK2 Mutation Detection Test
QClamp® KRAS Mutation Detection Test
QClamp® NRAS Mutation Detection Kit
QClamp® PIK3CA Mutation Detection Test
QFusion™ EML4-ALK and KIF5B-ALK Fusion Gene Detection Test
ColoScape™ Colorectal Cancer Mutation Detection Test
OptiSeq™ BRCA1 and BRCA2 Panel
OptiSeq™ Colorectal Cancer Panel
OptiSeq™ Lung Cancer & Colon Cancer Early Detection Panel
OptiSeq™ Lung Cancer Panel
OptiSeq™ Pan-Cancer Gene Panel
QClamp® BRAF Mutation Detection Test
QClamp® EGFR Mutation Detection Test
QClamp® JAK2 Mutation Detection Test
QClamp® KRAS Mutation Detection Test
QClamp® NRAS Mutation Detection Kit
QClamp® PIK3CA Mutation Detection Test
QFusion™ EML4-ALK and KIF5B-ALK Fusion Gene Detection Test
›
Details
Evidence
News
The RadTox™ test is a trailblazing test in monitoring cancer treatment by measuring cell-free DNA (cfDNA) levels that are increased in cancer patients because of rapid cancer cell proliferation and cell death (apoptosis).
Method:
Cell-free DNA
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.